Used as a key intermediate in the synthesis of antiviral agents, particularly NS5A inhibitors for hepatitis C virus (HCV). Its structure enables effective binding to the viral NS5A protein, inhibiting replication and reducing viral load. Valuable in medicinal chemistry for designing targeted inhibitors. The compound’s chiral center and functional groups allow for selective reactions, enhancing drug potency, metabolic stability, absorption, and suitability for oral administration. It is also employed in research for optimizing pharmacokinetic properties in new drug candidates with high specificity for biological targets.